The invention provides compounds of formula (I), ##STR00001## the pharmaceutically acceptable salts and solvates thereof, wherein A, B, R.sup.1, R.sup.2, and R.sup.7 are as defined herein; pharmaceutical compositions thereof; combinations thereof; and uses thereof as vasopressin V.sub.1A antagonists.

 
Web www.patentalert.com

< Methods and compositions for enhancing cellular function through protection of tissue components

< Inhibitors of macrophase migration inhibitory factor and methods for identifying the same

> Heterocyclic inhibitors of kinases

> Monoamine reuptake inhibitors for treatment of CNS disorders

~ 00278